StonvexLoading…
StonvexStonvexStonvexCore line items from NTNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-07-31 | Annual 2024 2024-07-31 | Annual 2023 2023-07-31 | Annual 2022 2022-07-31 |
|---|---|---|---|---|
Revenue | $2.54B | $2.15B | $1.86B | $1.58B |
Operating Income | $172.54M | $7.56M | $-207.15M | $-458.85M |
Net Income | $188.37M | $-124.78M | $-254.56M | $-798.95M |
EPS (Diluted) | $0.65 | $-0.51 | $-1.09 | $-3.62 |
Total Assets | $3.28B | $2.14B | $2.53B | $2.37B |
Total Liabilities | $3.98B | $2.87B | $3.23B | $3.17B |
Cash & Equivalents | $769.50M | $655.27M | $512.93M | $402.85M |
Free Cash Flow OCF − CapEx | $750.17M | $597.68M | $207.00M | $18.48M |
Shares Outstanding | 294.08K | 244.74K | 233.25K | 226.94M |